Diligence report Healthcare & Life Sciences / self-funded employer health benefits administration Late-stage private healthcare benefits unicorn

Collective Health

Collective Health Public-Source Startup Diligence Report

Proceed only with data-room diligence: public sources support eligibility as an uncovered private unicorn candidate, while the key investment questions are private financial quality, concentration, defensibility, compliance, and current governance terms.

Company profile

Collective Health Public-Source Startup Diligence Report

Collective Health has credible public unicorn, product, and customer/partner signals, but public evidence is insufficient to underwrite current valuation, revenue quality, customer concentration, cap-table economics, and legal/regulatory posture.

Website: collectivehealth.com
Sector: Healthcare & Life Sciences / self-funded employer health benefits administration
Geography: United States; headquartered San Francisco with Chicago and Lehi cited publicly
Stage: Late-stage private healthcare benefits unicorn
Known aliases: Collective Health, Collective Health, Inc., My Collective
Report version: 1.0
Timezone: UTC

Executive summary

Strengths

Public unicorn valuation anchor $1.50B is corroborated by CB Insights and funding/independent coverage.
Public product positioning and product modules are documented by official company sources.
Public customer, logo, or partner signals exist, though economics remain private.

Risks

Operating financials and unit economics are not public
Health benefits market carries regulatory, privacy, and claims-processing complexity
Strategic-partner and large-employer concentration are not disclosed

Gaps

Audited/reviewed financial statements, ARR/net revenue, gross margin, burn, cash, debt, and backlog
Cap table, option pool, liquidation preferences, investor rights, SAFEs/notes/warrants
Revenue/TPV/member/customer concentration, churn, renewal, NRR, and references
Roadmap, technical architecture, incident history, R&D spend, and security reports
Litigation, regulatory, IP, insurance, and material-contract schedules

Recommended next steps

Open financial/cap-table data room first, then customer/reference, product/security, legal/regulatory, HR, and governance workstreams.
Reconfirm private-company status, current valuation, and any post-public-source financings or exits directly with company counsel.
Do not rely on public logos or funding announcements as proof of revenue quality, retention, compliance, or valuation fairness.

Risk register

high medium likelihood

R-001: Operating financials and unit economics are not public

The $1.5B valuation and $280M Series F are supported, but revenue, gross margin, implementation costs, claims/payment economics, burn, and runway are not public.

Diligence request: Open a focused diligence request covering the underlying data room evidence, responsible executive interviews, and third-party verification before investment reliance.

high medium likelihood

R-002: Health benefits market carries regulatory, privacy, and claims-processing complexity

Collective Health processes sensitive employer and member benefit workflows; HIPAA/privacy posture, SOC reports, incidents, claims adjudication controls, and regulatory correspondence need diligence.

Diligence request: Open a focused diligence request covering the underlying data room evidence, responsible executive interviews, and third-party verification before investment reliance.

high unknown likelihood

R-003: Strategic-partner and large-employer concentration are not disclosed

HCSC and named employer logos are valuable signals, but revenue dependence, contract terms, renewals, and member counts by account are not public.

Diligence request: Open a focused diligence request covering the underlying data room evidence, responsible executive interviews, and third-party verification before investment reliance.

medium high likelihood

R-004: Crowded benefits/navigation competition could pressure growth and margins

Employer health navigation, TPA, and care delivery competitors create pricing and differentiation pressure.

Diligence request: Open a focused diligence request covering the underlying data room evidence, responsible executive interviews, and third-party verification before investment reliance.

Chapter 01

01Financial Information

Public sources verify Collective Health's unicorn valuation anchor but do not verify audited financials, revenue quality, cash runway, debt, or cap-table terms.

EC-001 EC-002 EC-009 EC-011

I.A Annual and quarterly financial information for the past three years

not publicly verifiable confidence: high

Annual and quarterly financial information for the past three years is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-009 EC-011

Evidence gaps

Private data-room support is required for Annual and quarterly financial information for the past three years before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-001: see risk register for Annual and quarterly financial information for the past three years implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Annual and quarterly financial information for the past three years.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Public financial quality and capital-structure signals
metric	public signal	verification status	diligence request
Revenue / ARR / net revenue	not disclosed in reviewed public sources	not_publicly_verifiable	Audited statements, ARR/net-revenue bridge, cohort retention, and revenue recognition policy
Cash, burn, runway, debt	not disclosed in reviewed public sources	not_publicly_verifiable	Cash balance, monthly burn, debt/credit agreements, off-balance-sheet liabilities
Capital structure	investors named publicly; ownership and preferences not public	partially_verified	Cap table, preferred terms, SAFEs/notes, option pool, warrants, investor rights

I.B Financial Projections

not publicly verifiable confidence: high

Financial Projections is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-001 EC-002

Evidence gaps

Private data-room support is required for Financial Projections before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-001: see risk register for Financial Projections implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Financial Projections.
Identify any material changes since the latest public source reviewed on 2026-06-03.

I.C Capital Structure

not publicly verifiable confidence: high

Capital Structure is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-001 EC-002

Evidence gaps

Private data-room support is required for Capital Structure before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-001: see risk register for Capital Structure implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Capital Structure.
Identify any material changes since the latest public source reviewed on 2026-06-03.

I.D Other financial information

not publicly verifiable confidence: high

Other financial information is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-001 EC-002 EC-011 EC-009

Evidence gaps

Private data-room support is required for Other financial information before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-001: see risk register for Other financial information implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Other financial information.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Public funding-round and valuation history
date	round or event	amount	post money valuation	lead or participants	verification status
2019-06-17	CB Insights unicorn row	not disclosed in row	$1.50B	New Enterprise Associates, Founders Fund, Google Ventures	verified via public unicorn database
2019-06-17	Latest major public financing / unicorn event	$280M Series F	$1.50B	New Enterprise Associates, Founders Fund, Google Ventures	verified/partially verified by public sources
2026-06-03	Current cap table and current valuation	not publicly disclosed	not publicly verifiable	request data room	not_publicly_verifiable

Funding and valuation event timeline Chronology of public funding and eligibility anchors.

Public valuation chart Single public valuation anchor with missing current valuation marked.

Chapter 02

02Products

Public sources describe Collective Health's product surface, but usage, roadmap performance, gross margin, and technical diligence remain private.

EC-003 EC-004 EC-007 EC-013

II.A Description of each product

partially verified confidence: medium

Public-source review found directional evidence for description of each product, with private validation needed before reliance.

EC-003 EC-004 EC-009 EC-007

Evidence gaps

Private data-room support is required for Description of each product before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Description of each product implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Description of each product.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Product / SKU matrix
product	audience	public features	verification status
Collective TPA	Self-funded employers	Plan administration, cost management, partner choice, data to optimize outcomes	verified
Navigation & Advocacy	Employees/members	Benefits front door, care navigation, complex-care support, member advocates	verified
Benefits Hub	Employers and members	Ancillary partner programs and Partner Collective tool in one platform	verified
Collective AI / CAI	Members, advocates, operations teams	AI companion, member-advocate tooling, enrollment and implementation workflows	verified

Pricing and packaging visibility
offering	public price	included or request	verification status
TPA administration pricing	Not publicly disclosed	Likely employer contract pricing; request rate card and implementation fees	not_publicly_verifiable
Navigation and advocacy pricing	Not publicly disclosed	Per-member/per-month or services model not public	not_publicly_verifiable
Partner ecosystem fees	Not publicly disclosed	Partner referral, integration, or pass-through economics not public	not_publicly_verifiable

Public product architecture / dependency map High-level public product components and external dependencies.

Chapter 03

03Customer Information

Public customer or partner signals exist, but revenue concentration, renewal status, churn, and contract economics are not public.

EC-005 EC-006 EC-010

III.A Top customers by application

partially verified confidence: medium

Public-source review found directional evidence for top customers by application, with private validation needed before reliance.

EC-005 EC-010

Evidence gaps

Private data-room support is required for Top customers by application before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Top customers by application implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Top customers by application.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Public customer / logo evidence
customer or logo	relationship type	public evidence	verification status
Pinterest	Self-funded employer case study	Reduced member issues by over 70% per official site	partially_verified
Activision Blizzard	Employer customer story	Average 20 hours of weekly work saved per official site	partially_verified
Zoom	Employer customer story	Behavioral health benefits example on official site	partially_verified
HCSC	Strategic insurer relationship	Self-funded Illinois/Texas customer channel beginning 2022	verified

III.B Strategic relationships

partially verified confidence: medium

Public-source review found directional evidence for strategic relationships, with private validation needed before reliance.

EC-006 EC-010

Evidence gaps

Private data-room support is required for Strategic relationships before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Strategic relationships implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Strategic relationships.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Strategic relationships, suppliers, and dependencies
relationship	nature	public evidence	gap or risk
Health Care Service Corporation	Strategic channel/investor relationship	HCSC offers Collective Health to self-funded customers; investment subject to regulatory approval	contract economics and governance not public
Premier Partner Program	Benefits partner ecosystem	Official site references vetted partner program	requires verification
Digital health and virtual provider programs	Curated programs	HCSC announcement describes curated programs using population data	requires verification

III.C Revenue by customer

not publicly verifiable confidence: high

Revenue by customer is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-005 EC-010

Evidence gaps

Private data-room support is required for Revenue by customer before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Revenue by customer implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Revenue by customer.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Customer concentration disclosure chart Known public logos have no disclosed revenue share.

III.D Significant relationships severed within the last two years

partially verified confidence: medium

Public-source review found directional evidence for significant relationships severed within the last two years, with private validation needed before reliance.

EC-005 EC-006

Evidence gaps

Private data-room support is required for Significant relationships severed within the last two years before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Significant relationships severed within the last two years implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Significant relationships severed within the last two years.
Identify any material changes since the latest public source reviewed on 2026-06-03.

III.E Top suppliers

partially verified confidence: medium

Public-source review found directional evidence for top suppliers, with private validation needed before reliance.

EC-005 EC-006

Evidence gaps

Private data-room support is required for Top suppliers before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Top suppliers implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Top suppliers.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Chapter 04

04Competition

The competitive landscape is identifiable from public positioning, but win/loss data and differentiation require private interviews and data.

EC-012

IV.A Competitive landscape by market segment

partially verified confidence: medium

Public-source review found directional evidence for competitive landscape by market segment, with private validation needed before reliance.

EC-012 EC-004 EC-007

Evidence gaps

Private data-room support is required for Competitive landscape by market segment before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-004: see risk register for Competitive landscape by market segment implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Competitive landscape by market segment.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Competitor comparison matrix
competitor	segment	product overlap	differentiator or pressure
Eden Health	direct-to-employer care/navigation	Market snapshot cites employer health-benefit-navigation tools	Care delivery plus navigation
Buoy Health	employer-facing health tooling	Market snapshot cites vaccination/workforce tools	Engagement and triage tools
Firefly Health	health plan and employer market	Market snapshot cites employer-sponsored market entrance	Plan offering plus primary care
Cleo	family benefits platform	Market snapshot cites employer-based family benefits	Niche family benefits depth

Basis-of-competition scoring
axis	target position	competitive pressure	evidence basis
Product breadth	credible public product suite	larger suites may bundle adjacent capabilities	official product pages
Trust/compliance	public compliance/security claims exist	buyers require independent reports and contracts	security/public trust sources
Pricing power	not fully verifiable from public data	competitive procurement and substitutes	pricing page or pricing gap

Competitive market map Qualitative map of target and competitor segments.

Chapter 05

05Marketing, Sales, and Distribution

Public GTM motions and proof points exist; channel mix, pipeline conversion, CAC, and sales productivity are not public.

EC-005 EC-006 EC-013

V.A Strategy and implementation

partially verified confidence: medium

Public-source review found directional evidence for strategy and implementation, with private validation needed before reliance.

EC-006 EC-013

Evidence gaps

Private data-room support is required for Strategy and implementation before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Strategy and implementation implications.
R-004: see risk register for Strategy and implementation implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Strategy and implementation.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Distribution channels and GTM motions
channel	public signal	region or segment	gap
Direct sales / demo motion	official site asks prospects to get started, request demo, or contact sales	United States	pipeline, conversion, CAC, sales cycle not public
Partner / ecosystem motion	Health Care Service Corporation; Premier Partner Program; Digital health and virtual provider programs	United States; headquartered San Francisco with Chicago and Lehi cited publicly	partner-sourced revenue and contracts not public
Content / product-led education	public website, docs/blog/events/resources	public web	traffic, lead quality, CAC payback not public

GTM channel mix disclosure chart Public channels are identifiable but channel weights are not public.

V.B Major Customers

partially verified confidence: medium

Public-source review found directional evidence for major customers, with private validation needed before reliance.

EC-005 EC-006 EC-007

Evidence gaps

Private data-room support is required for Major Customers before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Major Customers implications.
R-004: see risk register for Major Customers implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Major Customers.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Public marketing and customer-signal summary
signal	evidence	verification status	private validation needed
Named customers/logos	Pinterest, Activision Blizzard, Zoom, HCSC	partially_verified	signed contracts, ARR/TPV by account, reference calls
Funding/investor credibility	New Enterprise Associates, Founders Fund, Google Ventures	verified	investor rights, board composition, latest valuation
Product/security trust	official product and security/trust pages	partially_verified	third-party reports, pen tests, customer security questionnaires

V.C Principal avenues for generating new business

partially verified confidence: medium

Public-source review found directional evidence for principal avenues for generating new business, with private validation needed before reliance.

EC-005 EC-006

Evidence gaps

Private data-room support is required for Principal avenues for generating new business before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Principal avenues for generating new business implications.
R-004: see risk register for Principal avenues for generating new business implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Principal avenues for generating new business.
Identify any material changes since the latest public source reviewed on 2026-06-03.

V.D Sales force productivity model

not publicly verifiable confidence: high

Sales force productivity model is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-005 EC-006

Evidence gaps

Private data-room support is required for Sales force productivity model before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Sales force productivity model implications.
R-004: see risk register for Sales force productivity model implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Sales force productivity model.
Identify any material changes since the latest public source reviewed on 2026-06-03.

V.E Ability to implement marketing plan with current and projected budgets

partially verified confidence: medium

Public-source review found directional evidence for ability to implement marketing plan with current and projected budgets, with private validation needed before reliance.

EC-005 EC-006

Evidence gaps

Private data-room support is required for Ability to implement marketing plan with current and projected budgets before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-003: see risk register for Ability to implement marketing plan with current and projected budgets implications.
R-004: see risk register for Ability to implement marketing plan with current and projected budgets implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Ability to implement marketing plan with current and projected budgets.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Chapter 06

06Research and Development

Public product/R&D signals exist, but engineering roadmap, security design, product velocity, and technical debt require internal evidence.

EC-003 EC-004 EC-013 EC-014

VI.A Description of R&D organization

partially verified confidence: medium

Public-source review found directional evidence for description of r&d organization, with private validation needed before reliance.

EC-007 EC-013 EC-014

Evidence gaps

Private data-room support is required for Description of R&D organization before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Description of R&D organization.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Key R&D / product personnel and technical signals
signal	public evidence	verification status	diligence request
Founder / technical leadership	Ali Diab (CEO and Co-Founder); HCSC strategic relationship executives (Partner stakeholders); DFJ Growth, GV, NEA, SoftBank Vision Fund, Sun Life (Investors/backers)	partially_verified	Current org chart, invention assignments, retention packages
Developer/product resources	Platform, AI, partner ecosystem, member/employer apps	verified	Architecture, roadmap, security design, R&D budget
Technical claims	MobiHealthNews and HCSC announcement describe employer hub, claims and payment processing, dashboards, and member navigation.	partially_verified	Independent technical validation and incident history

R&D / platform ownership map Publicly visible technical/product roles and private org gaps.

VI.B New Product Pipeline

partially verified confidence: medium

Public-source review found directional evidence for new product pipeline, with private validation needed before reliance.

EC-003 EC-004 EC-013

Evidence gaps

Private data-room support is required for New Product Pipeline before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for New Product Pipeline.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Public product / research pipeline
initiative	public status	expected date	risk or gap
Collective TPA	available/marketed publicly	current public offering	usage and roadmap depth not public
Collective AI / CAI	available/marketed publicly or public module	current public offering	performance and customer adoption not public
Unannounced roadmap	not publicly disclosed	not_publicly_verifiable	request product roadmap, R&D milestones, build-vs-buy dependencies

Chapter 07

07Management and Personnel

Public leadership and hiring signals are limited; current org chart, compensation, retention, attrition, and employee relations require data-room review.

EC-006 EC-008 EC-014

VII.A Organization Chart

partially verified confidence: medium

Public-source review found directional evidence for organization chart, with private validation needed before reliance.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Organization Chart before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Organization Chart.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VII.B Historical and projected headcount by function and location

partially verified confidence: medium

Public-source review found directional evidence for historical and projected headcount by function and location, with private validation needed before reliance.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Historical and projected headcount by function and location before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Historical and projected headcount by function and location.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Headcount, hiring, and turnover signals
metric or signal	public value	source basis	diligence request
2013 founding	not publicly verified	founded; headcount not disclosed	headcount by function/location, attrition, offers, compensation, contractor mix, employee relations matters
2026 current headcount	not publicly verified	not publicly verified from fetched sources	headcount by function/location, attrition, offers, compensation, contractor mix, employee relations matters

Headcount disclosure trend Available workforce anchors and undisclosed current headcount.

VII.C Senior management biographies

partially verified confidence: medium

Public-source review found directional evidence for senior management biographies, with private validation needed before reliance.

EC-014

Evidence gaps

Private data-room support is required for Senior management biographies before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Senior management biographies.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Senior management and governance roster
name or group	role	public background	diligence caveat
Ali Diab	CEO and Co-Founder	Publicly quoted in 2021 funding/partnership sources	current employment, equity, board rights, inventions, and restrictive covenants require data-room review
HCSC strategic relationship executives	Partner stakeholders	Maurice Smith and Kevin Cassidy quoted by HCSC in relationship announcement	current employment, equity, board rights, inventions, and restrictive covenants require data-room review
DFJ Growth, GV, NEA, SoftBank Vision Fund, Sun Life	Investors/backers	Investor backing public; economics not disclosed	current employment, equity, board rights, inventions, and restrictive covenants require data-room review

VII.D Compensation arrangements

not publicly verifiable confidence: high

Compensation arrangements is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Compensation arrangements before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Compensation arrangements.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VII.E Incentive stock plans

not publicly verifiable confidence: high

Incentive stock plans is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Incentive stock plans before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Incentive stock plans.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VII.F Significant employee relations problems, past or present

partially verified confidence: medium

Public-source review found directional evidence for significant employee relations problems, past or present, with private validation needed before reliance.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Significant employee relations problems, past or present before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Significant employee relations problems, past or present.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VII.G Personnel Turnover

not publicly verifiable confidence: high

Personnel Turnover is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-006 EC-008

Evidence gaps

Private data-room support is required for Personnel Turnover before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Personnel Turnover.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Chapter 08

08Legal and Related Matters

Public security/compliance statements exist, but legal, regulatory, IP, insurance, and material-contract diligence are largely private.

EC-007 EC-015

VIII.A Pending lawsuits against the Company

not publicly verifiable confidence: high

Pending lawsuits against the Company is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-015

Evidence gaps

Private data-room support is required for Pending lawsuits against the Company before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Pending lawsuits against the Company implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Pending lawsuits against the Company.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Legal, litigation, and regulatory-action public summary
matter type	public finding	verification status	diligence request
Pending lawsuits against company	no comprehensive litigation schedule available in public sources reviewed	not_publicly_verifiable	counsel litigation search, representation letter, threatened claims
Company-initiated lawsuits	not surfaced in reviewed public sources	not_publicly_verifiable	counsel docket search and dispute schedule
Regulatory/agency actions	not comprehensively verifiable from public sources reviewed	not_publicly_verifiable	regulatory correspondence, exams, consent orders, license status

VIII.B Pending lawsuits initiated by Company

not publicly verifiable confidence: high

Pending lawsuits initiated by Company is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-007 EC-015

Evidence gaps

Private data-room support is required for Pending lawsuits initiated by Company before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Pending lawsuits initiated by Company implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Pending lawsuits initiated by Company.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VIII.C Environmental and employee safety issues and liabilities

partially verified confidence: medium

Public-source review found directional evidence for environmental and employee safety issues and liabilities, with private validation needed before reliance.

EC-007 EC-015

Evidence gaps

Private data-room support is required for Environmental and employee safety issues and liabilities before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Environmental and employee safety issues and liabilities implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Environmental and employee safety issues and liabilities.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VIII.D Material patents, copyrights, licenses, and trademarks

partially verified confidence: medium

Public-source review found directional evidence for material patents, copyrights, licenses, and trademarks, with private validation needed before reliance.

EC-007 EC-015

Evidence gaps

Private data-room support is required for Material patents, copyrights, licenses, and trademarks before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Material patents, copyrights, licenses, and trademarks implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Material patents, copyrights, licenses, and trademarks.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Material IP, contracts, security, and insurance requests
area	public evidence	verification status	request
Security/compliance	MobiHealthNews and HCSC announcement describe employer hub, claims and payment processing, dashboards, and member navigation.	partially_verified	SOC/ISO/PCI/HIPAA reports as applicable, pen tests, incident history, subprocessor list
IP ownership	no full patent/trademark/copyright/invention assignment schedule in public sources	not_publicly_verifiable	patent/trademark schedule, assignments, OSS/SBOM, founder/employee invention agreements
Material contracts and insurance	not publicly disclosed	not_publicly_verifiable	customer, supplier, partner, processor/cloud contracts; insurance binders and claims history

VIII.E Insurance coverage and material exposures

not publicly verifiable confidence: high

Insurance coverage and material exposures is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-007 EC-015

Evidence gaps

Private data-room support is required for Insurance coverage and material exposures before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Insurance coverage and material exposures implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Insurance coverage and material exposures.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VIII.F Material contracts

not publicly verifiable confidence: high

Material contracts is not fully publicly verifiable for a private company; public sources provide directional signals and the report lists required data-room follow-up.

EC-007 EC-015

Evidence gaps

Private data-room support is required for Material contracts before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Material contracts implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Material contracts.
Identify any material changes since the latest public source reviewed on 2026-06-03.

VIII.G Regulatory agency problems

partially verified confidence: medium

Public-source review found directional evidence for regulatory agency problems, with private validation needed before reliance.

EC-001 EC-002 EC-009 EC-003 EC-008 EC-015 EC-005 EC-006 EC-010 EC-012

Evidence gaps

Private data-room support is required for Regulatory agency problems before investment reliance.
Public sources may be stale, self-reported, or incomplete; validate with company management and third parties.

Hidden risks

R-002: see risk register for Regulatory agency problems implications.

Follow-up questions

Provide source documents, owner, date, and quantitative support for Regulatory agency problems.
Identify any material changes since the latest public source reviewed on 2026-06-03.

Legal/regulatory risk heatmap Risk heatmap for full public diligence risk register.

Evidence

Evidence claims
ID	Claim	Status	Sources
EC-001	Collective Health is listed as an uncovered unicorn at a $1.50B valuation.	verified high	SRC-001
EC-002	Collective Health raised $280M Series F and was valued at about $1.5B in 2021.	verified high	SRC-002
EC-003	Collective Health offers an independent TPA and health-benefits platform for self-funded employers.	verified high	SRC-003
EC-004	Collective Health products include Collective TPA, Navigation & Advocacy, Benefits Hub, and Collective AI.	verified high	SRC-003
EC-005	Public customer and case-study evidence includes Pinterest, Activision Blizzard, Zoom, and HCSC.	partially verified high	SRC-003 SRC-004
EC-006	The HCSC relationship is a major strategic partnership and channel signal.	verified high	SRC-004 SRC-002
EC-007	Collective Health positions the platform as administration, claims/payment processing, reporting, partner programs, and member experience.	verified high	SRC-002 SRC-004
EC-008	Collective Health maintains a responsible disclosure policy.	verified medium	SRC-005
EC-009	Public sources reviewed do not disclose audited financials, revenue quality, gross margin, burn, cash, claims float economics, or debt.	not publicly verifiable high	SRC-002 SRC-003
EC-010	Collective Health customer concentration and contract economics are not publicly verifiable.	not publicly verifiable high	SRC-003 SRC-004
EC-011	Collective Health appears still private based on private-market references and no reviewed top-result evidence of IPO, acquisition, or shutdown.	partially verified medium	SRC-001 SRC-006 SRC-007
EC-012	Collective Health competes in employer health-benefits administration and navigation markets.	verified medium	SRC-002
EC-013	Collective Health was founded in 2013 and is backed by healthcare and technology investors.	verified high	SRC-004
EC-014	Ali Diab is publicly cited as CEO and co-founder in 2021 sources.	verified high	SRC-002 SRC-004
EC-015	Collective Health public legal, regulatory, IP assignment, insurance, and material-contract diligence remains incomplete.	not publicly verifiable high	SRC-005 SRC-007

Sources
ID	Publisher	Title	Accessed
SRC-001	CB Insights	CB Insights Complete List of Unicorn Companies	2026-06-03
SRC-002	MobiHealthNews	Collective Health scores $280M to scale employer health benefits platform	2026-06-03
SRC-003	Collective Health	Collective Health official website	2026-06-03
SRC-004	Collective Health	HCSC and Collective Health strategic relationship announcement	2026-06-03
SRC-005	Collective Health	Collective Health Responsible Disclosure Policy	2026-06-03
SRC-006	DuckDuckGo	DuckDuckGo search: Collective Health IPO acquired private startup	2026-06-03
SRC-007	Collective Health	Collective Health Newsroom	2026-06-03

Disclaimer

This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.